| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.073 | 0.3 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.056 | 0.3 |